150 related articles for article (PubMed ID: 12865322)
1. Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter.
Cheng WS; Giandomenico V; Pastan I; Essand M
Endocrinology; 2003 Aug; 144(8):3433-40. PubMed ID: 12865322
[TBL] [Abstract][Full Text] [Related]
2. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
[TBL] [Abstract][Full Text] [Related]
3. A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer.
Cheng WS; Kraaij R; Nilsson B; van der Weel L; de Ridder CM; Tötterman TH; Essand M
Mol Ther; 2004 Aug; 10(2):355-64. PubMed ID: 15294182
[TBL] [Abstract][Full Text] [Related]
4. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
Gao N; Zhang J; Rao MA; Case TC; Mirosevich J; Wang Y; Jin R; Gupta A; Rennie PS; Matusik RJ
Mol Endocrinol; 2003 Aug; 17(8):1484-507. PubMed ID: 12750453
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin.
Wolfgang CD; Essand M; Lee B; Pastan I
Cancer Res; 2001 Nov; 61(22):8122-6. PubMed ID: 11719440
[TBL] [Abstract][Full Text] [Related]
6. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.
Pang S; Dannull J; Kaboo R; Xie Y; Tso CL; Michel K; deKernion JB; Belldegrun AS
Cancer Res; 1997 Feb; 57(3):495-9. PubMed ID: 9012480
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
8. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
[TBL] [Abstract][Full Text] [Related]
9. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
Pang S; Taneja S; Dardashti K; Cohan P; Kaboo R; Sokoloff M; Tso CL; Dekernion JB; Belldegrun AS
Hum Gene Ther; 1995 Nov; 6(11):1417-26. PubMed ID: 8573614
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
Suzuki S; Tadakuma T; Asano T; Hayakawa M
Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
[TBL] [Abstract][Full Text] [Related]
11. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
Yu DC; Sakamoto GT; Henderson DR
Cancer Res; 1999 Apr; 59(7):1498-504. PubMed ID: 10197620
[TBL] [Abstract][Full Text] [Related]
12. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
Majumdar S; Diamandis EP
Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
[TBL] [Abstract][Full Text] [Related]
13. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
14. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
[TBL] [Abstract][Full Text] [Related]
15. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
Lee SE; Jin RJ; Lee SG; Yoon SJ; Park MS; Heo DS; Choi H
Anticancer Res; 2000; 20(1A):417-22. PubMed ID: 10769689
[TBL] [Abstract][Full Text] [Related]
16. Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.
Zhang P; Zhang J; Young CY; Kao PC; Chen W; Jiang A; Zhang L; Guo Q
Ann Clin Lab Sci; 2005; 35(3):278-84. PubMed ID: 16081584
[TBL] [Abstract][Full Text] [Related]
17. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
Wu L; Matherly J; Smallwood A; Adams JY; Billick E; Belldegrun A; Carey M
Gene Ther; 2001 Sep; 8(18):1416-26. PubMed ID: 11571582
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells.
Wang LG; Liu XM; Kreis W; Budman DR
Cancer Res; 1997 Feb; 57(4):714-9. PubMed ID: 9044850
[TBL] [Abstract][Full Text] [Related]
19. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.
van den Bemd GJ; Jhamai M; Brinkmann AO; Chang GT
Biochem Biophys Res Commun; 2003 Dec; 312(3):578-84. PubMed ID: 14680804
[TBL] [Abstract][Full Text] [Related]
20. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element.
Verrijdt G; Schoenmakers E; Alen P; Haelens A; Peeters B; Rombauts W; Claessens F
Mol Endocrinol; 1999 Sep; 13(9):1558-70. PubMed ID: 10478846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
